Community-acquired pneumonia (CAP) is an infectious disease of the lungs that develops in individuals not currently hospitalized and is a leading cause of high morbidity and mortality worldwide. CAP tends to have a more severe course among patients with high-risk factors, which complicates therapeutic management. This article analyzes the categories of patients at increased risk for developing CAP. In particular, it addresses elderly individuals, those with immunosuppressive conditions, patients with chronic somatic diseases, individuals with low levels of social support (e.g., residents of nursing homes), as well as smokers and those who abuse alcohol. The article discusses the clinical characteristics of CAP in these populations, diagnostic approaches, the selection of antibiotic therapy based on individualized assessment, symptomatic care, and the effectiveness of preventive measures. Special attention is given to rehabilitation and follow-up strategies for patients who have experienced severe forms of CAP.
This article provides valuable information for physicians, epidemiologists, family medicine practitioners, and healthcare strategists for the early identification of high-risk groups and for developing a differentiated approach to their management. Such a systematic approach contributes to reducing the incidence and complications associated with pneumonia.

community-acquired pneumonia, risk factors, immunosuppression, elderly patients, chronic diseases, outpatient pneumonia, high-risk patient group.

Mandell, L. A., et al. (2007). Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia. Clinical Infectious Diseases.

World Health Organization. (2023). Pneumonia: Fact Sheet.

Torres, A., et al. (2013). Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax.

Niederman, M. S. (2009). Community-acquired pneumonia: the U.S. perspective. Seminars in Respiratory and Critical Care Medicine.

Мамажонов, И., & Маҳкамов, Н. (2024). Ковид-19 таъсири натижасида келиб чиққан туберкулёз спондилитнинг клиник ва диагностик ўзига хос хусусиятлари. Modern Science and Research, 3(10), 55–62.

Retrieved from: https://inlibrary.uz/index.php/science-research/article/view/46924

Ewig, S., et al. (2020). New perspectives on community-acquired pneumonia in 2020. Current Opinion in Pulmonary Medicine.

Джумабаева, С. Э., Насирдинов, М. А., Насирдинов, А. У., & Усмонова, У. И. (2019). Клинико-патогенетические особенности бронхиальной астмы. Экономика и социум, (9)64.

URL: https://cyberleninka.ru/article/n/kliniko-patogeneticheskie-osobennosti-bronhialnoy-astmy

(Дата обращения: 29.05.2025).

File, T. M. Jr. (2003). Community-acquired pneumonia. The Lancet.

Almirall, J., et al. (2000). The incidence of community-acquired pneumonia and the value of routine chest radiographs. European Respiratory Journal.

Bartlett, J. G. (2011). Diagnostic Tests for Agents of Community-Acquired Pneumonia. Clinical Infectious Diseases.

Musher, D. M., & Thorner, A. R. (2014). Community-acquired pneumonia. New England Journal of Medicine.

Centers for Disease Control and Prevention. (2022). Vaccines for Adults: Pneumococcal Vaccination.

Aliev A.L., Kuziev D.V., Akhrorkhonov R.A., Ashuralieva M.A. Some Indicators of Immune Status in Severe Pneumonia in Young Children with Acute Herpetic Stomatitis // American Journal of Medicine and Medical Sciences -2022, 12(11), С:1148-1151. (Америка мамлакатлари нашрлари, №1).

Кузиев Д.В., Алиев А.Л. Клинико-анамнестические особенности течения тяжёлых пневмоний у детей раннего возраста на фоне инфекционного токсикоза // Тиббиётда янги кун. 2022., №3(41)., С:127-129. (14.00.00, №22).